Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib (Q37687133)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 August 2016

Language	Label	Description	Also known as
English	Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib	scientific article published on 24 August 2016

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib (English)

1 reference

Europe PubMed Central

22 August 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Francesco Giuseppe Foschi

object named as

Francesco Giuseppe Foschi

10

0 references

object named as

Luca Faloppi

3

0 references

Andrea Casadei Gardini

object named as

Andrea Casadei Gardini

1

0 references

Daniele Santini

6

object named as

Daniele Santini

1 reference

Europe PubMed Central

22 August 2017

Nicola Silvestris

5

object named as

Nicola Silvestris

1 reference

Europe PubMed Central

22 August 2017

author name string

Emanuela Scarpi

2

1 reference

Europe PubMed Central

22 August 2017

Mario Scartozzi

4

1 reference

Europe PubMed Central

22 August 2017

Giorgio de Stefano

7

1 reference

Europe PubMed Central

22 August 2017

Giorgia Marisi

8

1 reference

Europe PubMed Central

22 August 2017

Francesca V Negri

9

1 reference

Europe PubMed Central

22 August 2017

Martina Valgiusti

11

1 reference

Europe PubMed Central

22 August 2017

Giorgio Ercolani

12

1 reference

Europe PubMed Central

22 August 2017

Giovanni Luca Frassineti

13

1 reference

Europe PubMed Central

22 August 2017

language of work or name

0 references

publication date

24 August 2016

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

7

1 reference

Europe PubMed Central

22 August 2017

41

1 reference

Europe PubMed Central

22 August 2017

67142-67149

1 reference

Europe PubMed Central

22 August 2017

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Immune infiltration in human tumors: a prognostic factor that should not be ignored

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Sorafenib for the treatment of unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 August 2017

Immunological landscape and immunotherapy of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

6 September 2017

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

6 September 2017

Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

6 September 2017

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

14 September 2017

Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

14 September 2017

Role of lymphocytes in liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

23 June 2018

Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

1 September 2018

Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

1 September 2018

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

1 September 2018

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

1 September 2018

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5341863

1 September 2018

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27613839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27613839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation lights the way to metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27613839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.11565

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37687133&oldid=1732900477"